BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 25
• 26
• 30
• 31

• Drug Development

  Protalix Announces FDA Investigational New Drug Clearance To Commence Once-Monthly Dosing Study Of Pegunigalsidase Alfa (PRX-102) For The Treatment Of Fabry Disease

  May 9, 2017

   · 

  7 min read
• Business

  Zynerba Reports First Quarter 2017 Financial Results And Operational Highlights

  May 9, 2017

   · 

  1 min read
• Drug Development

  Crinetics Pharmaceuticals Initiates Phase I Study of Lead Candidate CRN00808 for Acromegaly

  CRN00808 is a nonpeptide somatostatin agonist designed to be taken orally to free patients from painful injected therapies and the scheduling of frequent clinic visits to receive them.

  May 9, 2017

   · 

  3 min read
• Business

  Alliqua Biomedical Reports First Quarter Of Fiscal Year 2017 Financial Results

  May 9, 2017

   · 

  1 min read
• Business

  AcelRx Reports First Quarter 2017 Financial Results And Provides Corporate Update

  May 9, 2017

   · 

  10 min read
• Business

  Pfenex Reports First Quarter 2017 Results and Provides Business Update

  May 9, 2017

   · 

  4 min read
• Business

  Nevro Reports First Quarter 2017 Financial Results

  May 9, 2017

   · 

  2 min read
• Business

  Coherus Reports First Quarter 2017 Corporate Highlights And Financial Results

  May 9, 2017

   · 

  2 min read
• Portage Biotech’s Holding In Biohaven

  May 9, 2017

   · 

  1 min read
• Business

  Pernix To Report First Quarter 2017 Financial Results On Monday, May 15

  May 9, 2017

   · 

  1 min read